Cargando…

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study

OBJECTIVE: Patients with diabetes mellitus have an increased risk of fractures; however, the underlying mechanism is largely unknown. We aimed to investigate whether the risk of major osteoporotic fractures in diabetes patients differs between subjects initiated with alendronate and denosumab, respe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viggers, Rikke, Al-Mashhadi, Zheer, Starup-Linde, Jakob, Vestergaard, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825412/ https://www.ncbi.nlm.nih.gov/pubmed/35154013 http://dx.doi.org/10.3389/fendo.2021.826997

Ejemplares similares

Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
por: Viggers, Rikke, et al.
Publicado: (2021)

The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

Predictors of Mortality Subsequent to a Fracture in Diabetes Mellitus Patients
por: Westberg-Rasmussen, Sidse, et al.
Publicado: (2015)

Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes
por: Starup-Linde, Jakob Kau, et al.
Publicado: (2021)

Associations with fracture in patients with diabetes: a nested case–control study
por: Starup-Linde, Jakob, et al.
Publicado: (2016)

Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation
por: Pedersen, Alma B., et al.
Publicado: (2019)

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients
por: Hsu, Tsuen-Wei, et al.
Publicado: (2019)

Editorial: Diabetes and bone - from cell to human
por: Vestergaard, Peter, et al.
Publicado: (2022)

Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)

Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

The Effects of 12-Weeks Whey Protein Supplements on Markers of Bone Turnover in Adults With Abdominal Obesity – A Post Hoc Analysis
por: Fuglsang-Nielsen, Rasmus, et al.
Publicado: (2022)

What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia
por: Karnon, Jonathan, et al.
Publicado: (2016)

Effect of Denosumab and Teriparatide on Fracture Nonunion
por: Boutin, Regine, et al.
Publicado: (2023)

Glucose Tolerance Tests and Osteocalcin Responses in Healthy People
por: Starup-Linde, Jakob, et al.
Publicado: (2018)

Bone Mineral Density After Transitioning From Denosumab to Alendronate
por: Kendler, David, et al.
Publicado: (2019)

Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence
por: Wang, Ke-Meng, et al.
Publicado: (2022)

Exosomes: A Friend or Foe for Osteoporotic Fracture?
por: Yang, Zhimin, et al.
Publicado: (2021)

Editorial: Assessment of osteoporotic fractures and risk prediction
por: Cheng, Xiaoguang, et al.
Publicado: (2022)

Bone Density and Structure in Overweight Men With and Without Diabetes
por: Starup-Linde, Jakob, et al.
Publicado: (2022)

Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures
por: Wang, Baohui, et al.
Publicado: (2022)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Association between Serum Cholesterol Level and Osteoporotic Fractures
por: Wang, Yanmao, et al.
Publicado: (2018)

The “Three in One” Bone Repair Strategy for Osteoporotic Fractures
por: Chen, Xiao, et al.
Publicado: (2022)

The impact of fasting plasma glucose variability on osteoporotic fractures
por: Liu, Ri, et al.
Publicado: (2023)

Antiresorptive-associated spontaneous fractures of both tibiae, followed by an atypical femur fracture during the sequential treatment with alendronate, denosumab then teriparatide
por: Tan, Juan, et al.
Publicado: (2019)

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
por: Everts-Graber, Judith, et al.
Publicado: (2023)

Expert consensus on the bone repair strategy for osteoporotic fractures in China
por: Zhang, Hao, et al.
Publicado: (2022)

Editorial: Assessment of osteoporotic fractures and risk prediction, volume II
por: Xie, Dandan, et al.
Publicado: (2023)

Effect of Lactobacillus casei fermented milk on fracture healing in osteoporotic mice
por: Guo, Xing, et al.
Publicado: (2022)

Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
por: Everts-Graber, Judith, et al.
Publicado: (2023)

Skeletal Fragility in Type 2 Diabetes Mellitus
por: Starup-Linde, Jakob, et al.
Publicado: (2018)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
por: Brunova, Jana, et al.
Publicado: (2018)

Case Report: Prophylactic Plate Fixation for Incomplete Atypical Ulnar Fractures Resulting From the Use of Denosumab for Bone Metastases
por: Murai, Atsuro, et al.
Publicado: (2022)

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
por: Iwamoto, Jun, et al.
Publicado: (2011)

Season of Birth and the Risk of Hip Fracture in Danish Men and Women Aged 65+
por: Abrahamsen, Bo, et al.
Publicado: (2012)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab
por: Anastasilakis, Athanasios D., et al.
Publicado: (2023)

Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis
por: Oshagbemi, O. A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_65112mjer5ni1cej24fi9c1acm